Recent Updates
Recently added Catalysts
ORIC Positive Sentiment Score: 65/100

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

Key Takeaway: ORIC Pharmaceuticals, a clinical-stage oncology firm, announced that its management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 2:00 p.m. ET. This event aims to boost the company’s visibility in the healthcare sector. Investors can access the live webcast through the company's website, with replays available for 90 days following the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is actively participating in a prominent healthcare conference.
  • Management engagement in industry events enhances company visibility.
  • The opportunity for live webcasts provides transparency and accessibility for investors.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) --  ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 2:00 p.m. ET.
The live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer

Frequently Asked Questions

When is ORIC Pharmaceuticals participating in the Oppenheimer Conference?

ORIC Pharmaceuticals will participate on March 13, 2023, at 2:00 p.m. ET.

Where can I watch the ORIC Pharmaceuticals webcast?

The webcast will be available on the investor section of ORIC's website.

How long will the webcast replay be available?

Replays of the webcasts will be available for 90 days after the event.

Who is the Chief Financial Officer of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer of ORIC Pharmaceuticals.

Last updated: Mar 6, 2023